4//SEC Filing
Patel Sujal M 4
Accession 0001808805-25-000034
CIK 0001808805other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:44 PM ET
Size
8.8 KB
Accession
0001808805-25-000034
Insider Transaction Report
Form 4
Patel Sujal M
DirectorCEO, President, and Secretary10% Owner
Transactions
- Purchase
Common Stock
2025-03-19$0.99/sh+53,300$53,028→ 10,117,788 total - Purchase
Common Stock
2025-03-20$1.00/sh+23,933$23,890→ 10,141,721 total
Holdings
- 1,814,035(indirect: By Trust)
Common Stock
- 5,280,476(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]Represents the weighted average share price of an aggregate total of 53,300 shares purchased in the price range of $0.9469 to $1.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 23,933 shares purchased in the price range of $0.9351 to $1.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
- [F4]Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
Documents
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001378830
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 4:44 PM ET
- Size
- 8.8 KB